Knoll Capital Management, LLC Diversified Active

CIK: 0001325083 · Show all filings

Period: Q4 2015 (← Previous) (Next →)

Filing Date: Feb 17, 2016

Total Value ($000): $269,729 (100.0% shares, 0.0% debt)

Holdings (21)

— Medivation, Inc. 78.8%

Value ($000) $212,591 Shares 4,397,838 Est. Cost $45.85 Unrealized —

— Ampio Pharmaceuticals Inc. 4.4%

Value ($000) $11,859 Shares 3,388,322 Est. Cost $6.03 Unrealized —

— Synthetic Biologics Inc. 3.2%

Value ($000) $8,551 Shares 3,734,149 Est. Cost $1.55 Unrealized —

— Alcobra Ltd 2.6%

Value ($000) $7,004 Shares 1,115,315 Est. Cost $7.08 Unrealized —

— Cempra Inc 2.1%

Value ($000) $5,628 Shares 180,800 Est. Cost $31.13 Unrealized —

— Abeona Therapeutics Inc 1.7%

Value ($000) $4,569 Shares 1,359,767 Est. Cost $5.06 Unrealized —

— Corbus Pharmaceuticals HLDGS 1.6%

Value ($000) $4,230 Shares 2,563,925 Est. Cost $2.53 Unrealized —

— Newlink Genetics Corp 1.4%

Value ($000) $3,728 Shares 102,437 Est. Cost $27.98 Unrealized —

— Advaxis Inc. 1.0%

Value ($000) $2,767 Shares 275,000 Est. Cost $10.06 Unrealized —

— Vascular Biologics LTD 0.6%

Value ($000) $1,753 Shares 333,332 Est. Cost $5.26 Unrealized —

— Bio Blast Pharma Ltd 0.5%

Value ($000) $1,312 Shares 338,110 Est. Cost $7.27 Unrealized —

— OHR Pharmaceutical Inc 0.5%

Value ($000) $1,259 Shares 205,000 Est. Cost $2.54 Unrealized —

— Keryx Biopharmaceuticals Inc. 0.4%

Value ($000) $1,010 Shares 200,000 Est. Cost $10.21 Unrealized —

ALDX Aldeyra Therapeutics Inc 0.3%

Value ($000) $921 Shares 135,800 Est. Cost $10.20 Unrealized -34.2%

— Advaxis Inc. 0.3%

Value ($000) $798 Shares 112,500 Est. Cost $7.09 Unrealized —

— Caladrius Biosciences Inc 0.2%

Value ($000) $600 Shares 555,781 Est. Cost $1.87 Unrealized —

— Galmed Pharmaceuticals Ltd 0.2%

Value ($000) $495 Shares 65,000 Est. Cost $11.48 Unrealized —

CSBR Champions Oncology INC 0.1%

Value ($000) $397 Shares 111,111 Est. Cost $4.66 Unrealized 0.0%

— Evoke Pharma Inc 0.1%

Value ($000) $184 Shares 55,660 Est. Cost $7.00 Unrealized —

— Zosano Pharma Corp 0.0%

Value ($000) $42 Shares 18,600 Est. Cost $10.10 Unrealized —

— Aptose Biosciences Inc 0.0%

Value ($000) $31 Shares 11,933 Est. Cost $5.40 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Medivation, Inc.	4,397,838	$212,591	78.8%	$45.85	—	COM	58501N101
—	Ampio Pharmaceuticals Inc.	3,388,322	$11,859	4.4%	$6.03	—	COM	03209T109
—	Synthetic Biologics Inc.	3,734,149	$8,551	3.2%	$1.55	—	COM	87164U102
—	Alcobra Ltd	1,115,315	$7,004	2.6%	$7.08	—	SHS	M2239P109
—	Cempra Inc	180,800	$5,628	2.1%	$31.13	—	COM	15130J109
—	Abeona Therapeutics Inc	1,359,767	$4,569	1.7%	$5.06	—	COM	00289Y107
—	Corbus Pharmaceuticals HLDGS	2,563,925	$4,230	1.6%	$2.53	—	COM	21833P103
—	Newlink Genetics Corp	102,437	$3,728	1.4%	$27.98	—	COM	651511107
—	Advaxis Inc.	275,000	$2,767	1.0%	$10.06	—	COM NEW	007624208
—	Vascular Biologics LTD	333,332	$1,753	0.6%	$5.26	—	COM	96883109
—	Bio Blast Pharma Ltd	338,110	$1,312	0.5%	$7.27	—	SHS	M20156101
—	OHR Pharmaceutical Inc	205,000	$1,259	0.5%	$2.54	—	COM NEW	67778H200
—	Keryx Biopharmaceuticals Inc.	200,000	$1,010	0.4%	$10.21	—	COM	492515101
ALDX	Aldeyra Therapeutics Inc	135,800	$921	0.3%	$10.20	-34.2%	COM	01438T106
—	Advaxis Inc.	112,500	$798	0.3%	$7.09	—	W EXP 07/15/201	007624117
—	Caladrius Biosciences Inc	555,781	$600	0.2%	$1.87	—	COM	128058104
—	Galmed Pharmaceuticals Ltd	65,000	$495	0.2%	$11.48	—	SHS	M47238106
CSBR	Champions Oncology INC	111,111	$397	0.1%	$4.66	0.0%	COMM NEW	15870P307
—	Evoke Pharma Inc	55,660	$184	0.1%	$7.00	—	COM	30049G104
—	Zosano Pharma Corp	18,600	$42	0.0%	$10.10	—	COM	98979H103
—	Aptose Biosciences Inc	11,933	$31	0.0%	$5.40	—	COM NEW	03835T200